Marci M, Albiani B, Ricci M, Russo F
Divisione di Medicina Generale, USL RM/G, Ospedale A. Angelucci di Subiaco.
Clin Ter. 1995 Mar;146(3):211-4.
The authors provide evidence for the efficacy of the buflomedil-pentoxifylline-defibrotide combination for treatment of lower limb chronic obstructive arterial disease, Fontain stage II. Improvement of walking autonomy obtained with these agents ranged from 50 to 100% in 29 of 36 patients (relative frequency = 0.80).
作者提供了丁咯地尔 - 己酮可可碱 - 去纤苷联合用药治疗Fontain II期下肢慢性阻塞性动脉疾病疗效的证据。在36例患者中的29例(相对频率 = 0.80)中,使用这些药物后步行自主性的改善幅度为50%至100%。